Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity Current Strategies in Managing Obesity STRIVE Obesity Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Cagrilintide, an amylin analog, enhances the weight loss effects of semaglutide or tirzepatide by slowing gastric emptying, suppressing glucagon, and reducing appetite. It works synergistically with Cagrilintide Peptide for Weight Loss Appetite Control & Metabolic Support